Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-16

FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Feraheme (ferumoxytol) from AMAG Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Feraheme (ferumoxytol)

Snippet

SUPPL AP for FERAHEME (FERUMOXYTOL)